JULIO
ARRIZABALAGA AGUIRREAZALDEGUI
Hospital Universitario La Paz
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (18)
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
2017
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2011
-
Restoration of T cell responses to Toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis
Clinical Infectious Diseases, Vol. 52, Núm. 5, pp. 662-670
2010
-
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: Three-year results (The Advanz Trial): A randomized, controlled trial
AIDS Research and Human Retroviruses, Vol. 26, Núm. 7, pp. 747-757
2009
-
(Enfermedades Infecciosas y Microbiologia Clinica (2009) 27, 4, (222-235))
Enfermedades Infecciosas y Microbiologia Clinica
-
The Spanish HIV BioBank: A model of cooperative HIV research
Retrovirology, Vol. 6
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2005
2004
-
Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH. Recomendaciones de GESIDA/Plan Nacional sobre el Sida. Año 2003
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 160-176
-
Recomendaciones de GESIDA/Plan Nacional sobre el sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (Octubre 2004)
Enfermedades Infecciosas y Microbiologia Clinica
2003
-
Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: A multicenter study of 67 cases
Chest, Vol. 123, Núm. 6, pp. 1970-1976
2002
-
Spanish GESIDA/national AIDS plan recommendations for antiretroviral therapy in HIV-infected adults in the year 2002
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. 6, pp. 244-303
1998
-
Avances en el diagnostico y tratamiento de las infecciones causadas por Herpesvirus y virus JC
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 16, Núm. SUPPL. 1, pp. 11-19